BETTELLI, Stefania Raffaella
 Distribuzione geografica
Continente #
NA - Nord America 7.933
EU - Europa 3.441
AS - Asia 2.865
SA - Sud America 441
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 14.747
Nazione #
US - Stati Uniti d'America 7.837
GB - Regno Unito 1.003
SG - Singapore 905
CN - Cina 836
IT - Italia 638
HK - Hong Kong 399
DE - Germania 390
BR - Brasile 363
SE - Svezia 354
IE - Irlanda 285
VN - Vietnam 196
UA - Ucraina 152
RU - Federazione Russa 150
FI - Finlandia 139
TR - Turchia 117
IN - India 74
ID - Indonesia 62
FR - Francia 61
JP - Giappone 61
BG - Bulgaria 57
CA - Canada 55
KR - Corea 50
NL - Olanda 41
PL - Polonia 40
AR - Argentina 35
MX - Messico 28
BE - Belgio 22
BD - Bangladesh 21
LT - Lituania 21
PK - Pakistan 21
ZA - Sudafrica 20
IQ - Iraq 18
AT - Austria 15
MY - Malesia 15
CZ - Repubblica Ceca 14
IR - Iran 11
ES - Italia 10
EC - Ecuador 9
CL - Cile 8
CO - Colombia 8
EG - Egitto 8
SA - Arabia Saudita 8
VE - Venezuela 8
DK - Danimarca 7
RO - Romania 7
TW - Taiwan 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
AZ - Azerbaigian 5
EU - Europa 5
GR - Grecia 5
IL - Israele 5
MA - Marocco 5
NP - Nepal 5
PY - Paraguay 5
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
NO - Norvegia 4
PH - Filippine 4
TH - Thailandia 4
TZ - Tanzania 4
AM - Armenia 3
AU - Australia 3
BO - Bolivia 3
DZ - Algeria 3
GA - Gabon 3
GE - Georgia 3
LB - Libano 3
LK - Sri Lanka 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
JM - Giamaica 2
ME - Montenegro 2
MK - Macedonia 2
MT - Malta 2
PT - Portogallo 2
SI - Slovenia 2
TN - Tunisia 2
UG - Uganda 2
AO - Angola 1
AP - ???statistics.table.value.countryCode.AP??? 1
BB - Barbados 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
GN - Guinea 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
Totale 14.735
Città #
Fairfield 817
Santa Clara 755
Ashburn 703
Southend 660
Singapore 619
Chandler 497
Woodbridge 437
Hong Kong 390
Houston 357
Seattle 344
Ann Arbor 294
Cambridge 284
Dublin 284
Wilmington 266
Jacksonville 262
Dearborn 260
Nyköping 226
Hefei 202
Beijing 175
London 167
Chicago 156
Los Angeles 147
New York 122
Dallas 111
Modena 107
Munich 83
Salt Lake City 77
Helsinki 75
The Dalles 75
Ho Chi Minh City 74
Izmir 68
Princeton 60
San Diego 59
Sofia 57
Tokyo 55
Council Bluffs 54
Moscow 51
Eugene 50
Jakarta 47
Seoul 44
Shanghai 43
Bologna 40
Milan 40
Hanoi 39
Tampa 38
São Paulo 37
Buffalo 35
Elk Grove Village 33
Fremont 32
Falls Church 31
Rome 28
Turku 27
Warsaw 25
Bremen 24
Columbus 24
Sterling 24
Dong Ket 23
Orem 22
Ottawa 22
Phoenix 20
Brussels 18
Frankfurt am Main 18
Redwood City 17
Norwalk 16
Brooklyn 15
Denver 15
Lahore 15
Redondo Beach 15
Boston 14
Lancaster 14
Mexico City 14
Nuremberg 14
Parma 13
San Jose 13
Stockholm 12
Atlanta 11
Brno 11
Lansdale 11
Naples 11
Hyderabad 10
Johannesburg 10
Des Moines 9
Grafing 9
Kunming 9
Nanjing 9
Poplar 9
Reggio Emilia 9
San Francisco 9
San Giuliano Milanese 9
Ankara 8
Belo Horizonte 8
Boardman 8
Charleston 8
Curitiba 8
Guangzhou 8
Lauterbourg 8
Mumbai 8
Padova 8
Portsmouth 8
Toronto 8
Totale 10.625
Nome #
Alterations of 9p21 analysed by FISH and MLPA distinguish atypical spitzoid melanocytic tumours from conventional Spitz's nevi but do not predict their biological behaviour 387
Atypical Spitzoid melanocytic tumors:A morphological, mutational, and FISH analysis 377
Cytomegalovirus infection of the upper gastrointestinal tract: a clinical and pathological study of 30 cases. 374
Poorly differentiated clusters (PDC) in colorectal cancer: What is and ought to be known. 374
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 373
Assessment of freezing effects and diagnostic potential of BioBank healthy and neoplastic breast tissues through HR-MAS NMR spectroscopy 372
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 353
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus 323
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 321
Clinical and molecular analysis of long-term HER2 positive metastatic breast cancer survivors. 318
Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis 302
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 301
Molecular Profile, as detected with Mass-Array Spectrometry (Sequenom platform), in primary and metastatic breast carcinoma treated with Exemestane + Everolimus 289
Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients. 284
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 281
Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer.. 278
Prediction of distant recurrence in resected stage I and II lung adenocarcinoma 271
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status 271
Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer 270
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study 267
Molecular profile in primary and metastatic breast cancer treated with Exemestane and Everolimus. 257
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis 257
Durable remission in a patient with leptomeningeal relapse of a MYC/BCL6-positive double-hit DLBCL treated with lenalidomide monotherapy 255
Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer 254
Does HPV play a role in the etiopathogenesis of ameloblastoma? An immunohistochemical, in situ hybridization and polymerase chain reaction study of 18 cases using laser capture microdissection 253
ASSESSMENT OF FREEZING EFFECTS AND DIAGNOSTIC POTENTIAL OF BIOBANK HEALTHY AND NEOPLASTIC BREAST TISSUES THROUGH HR-MAS NMR SPECTROSCOPY 252
Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients 251
Alveolar rhabdomyosarcoma of the uterine cervix. A case report confirmed by FKHR break-apart rearrangement using a fluorescence in situ hybridization probe on paraffin-embedded tissues. 249
Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with trastuzumab and lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive breast cancer 245
Expression of estrogen receptor in hemangioma of the uterine cervix: Reports of three cases and review of the literature 243
Cerebrospinal fluid cytology in a case of primary diffuse leptomeningeal and pineal melanocytic lesion, with histological confirmation 238
Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy. 236
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status. 220
Detection of human papillomavirus DNA in urinary bladder carcinoma by in situ hybridization 219
Prognostic impact of estrogen receptor (ER) level changes during progression for patients with both ER-positive (ER+) primary breast cancer and paired recurrence 214
Clinical impact and prognostic role of KRAS/BRAF/PIK3CA mutations in stage I colorectal cancer 213
EGFR polysomy in squamous cell carcinoma of the thyroid. Report of two cases and review of the literature 212
Trans-CHER-Lob: A Biomarker Analysis of the Randomized Phase II Study of Neoadjuvant Chemotherapy Plus Trastuzumab, Lapatinib or Combined Trastuzumab and Lapatinib in HER2 Positive Operable Breast Cancer. 208
Microsatellite and EGFR, HER2 and K-RAS analyses in sclerosing hemangioma of the lung 208
Change in HER2 Status in HER2 Positive Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without Anti-HER2 Therapy: Analysis of Two Consecutive Cohorts 208
The prognostic role of c-kit protein expression in resected large cell neuroendocrine carcinoma of the lung 206
Prediction of Distant Recurrence-Free Survival in Resectable Lung Adenocarcinoma. 205
Preoperative letrozole plus lapatinib/placebo for HR+/HER2 negative operable breast cancer: biomarker analyses of the randomized phase II LET-LOB study 203
High-Resolution Melting is a sensitive, cost-effective, time-saving technique for BRAF V600E detection in thyroid FNAB washing fluid: a prospective cohort study 202
COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS 197
Predictors of HER2 gene amplification in immunohistochemistry score 2+ Early Breast Cancer according to 2018 ASCO/CAP guidelines: a single institution analysis. 192
35. PREDICTORS OF HER2 FISH POSITIVITY IN PRIMARY BREAST CANCER DIAGNOSIS SCORED 2+ WITH IHC: RESULTS OF A SINGLE INSTITUTION ANALYSIS 191
Correlation between CD133 expression and mgmt status in recurrences melanoma 187
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients 173
Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting 171
FISH analysis in cell touch preparations and cytological specimens from formalin-fixed fetal autopsies 170
Prognostic role of HER2 loss after neoadjuvant therapy in patients with HER2-positive operable breast cancer 168
Evaluation of the effects of cryopreservation on Modena Biobank tissue samples through HR-MAS NMR 165
KRAS, NRAS, BRAF mutations and high counts of poorly differentiated clusters of neoplastic cells in colorectal cancer: Observational analysis of 175 cases 161
CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice 159
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 153
Histopathological variables in liver metastases of patients with stage IV colorectal cancer: potential prognostic relevance of poorly differentiated clusters 150
Deepening the knowledge of ros1 rearrangements in non-small cell lung cancer: Diagnosis, treatment, resistance and concomitant alterations 150
Morphological analysis of three extrathoracic bronchogenic cysts simulating neoplasms 140
Clinicopathological, cytogenetic, and molecular profiles of primary cutaneous diffuse large B-cell lymphomas 130
Unexpected tumor response to palliative pelvic radiotherapy in mismatch repair-deficient advanced prostate cancer: a case report 129
Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience 99
Correction to: Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy (British Journal of Cancer, (2010), 103, 7, (1019-1024), 10.1038/sj.bjc.6605853) 55
A Novel Molecular Profile of Hormone-Sensitive Prostate Cancer Defines High Risk Patients 45
Totale 14.879
Categoria #
all - tutte 57.357
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.357


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021866 0 0 0 0 0 89 103 182 103 173 114 102
2021/20221.179 52 128 94 71 40 91 54 58 121 123 202 145
2022/20231.520 149 164 117 122 121 178 35 115 400 13 46 60
2023/2024937 18 53 47 91 160 68 194 114 23 21 55 93
2024/20252.807 77 30 78 217 565 446 201 159 313 138 220 363
2025/20263.369 410 192 492 727 1.147 401 0 0 0 0 0 0
Totale 14.879